C

China Resources Pharmaceutical Group Ltd
HKEX:3320

Watchlist Manager
China Resources Pharmaceutical Group Ltd
HKEX:3320
Watchlist
Price: 5.18 HKD -2.81% Market Closed
Market Cap: 32.5B HKD
Have any thoughts about
China Resources Pharmaceutical Group Ltd?
Write Note

China Resources Pharmaceutical Group Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Resources Pharmaceutical Group Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Effect of Foreign Exchange Rates
HK$6.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Effect of Foreign Exchange Rates
-HK$124.1m
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
N/A
S
SSY Group Ltd
HKEX:2005
Effect of Foreign Exchange Rates
HK$1.5m
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
31%
U
United Laboratories International Holdings Ltd
HKEX:3933
Effect of Foreign Exchange Rates
-ÂĄ892k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
16%
Sino Biopharmaceutical Ltd
HKEX:1177
Effect of Foreign Exchange Rates
ÂĄ90.5m
CAGR 3-Years
-30%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Effect of Foreign Exchange Rates
-$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
-23%
No Stocks Found

China Resources Pharmaceutical Group Ltd
Glance View

Market Cap
32.5B HKD
Industry
Pharmaceuticals

China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The firm mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Intrinsic Value
16.46 HKD
Undervaluation 69%
Intrinsic Value
Price
C

See Also

What is China Resources Pharmaceutical Group Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
6.1m HKD

Based on the financial report for Jun 30, 2024, China Resources Pharmaceutical Group Ltd's Effect of Foreign Exchange Rates amounts to 6.1m HKD.

What is China Resources Pharmaceutical Group Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 1Y
-99%

Over the last year, the Effect of Foreign Exchange Rates growth was -99%.

Back to Top